RecruitingPhase 3NCT07582835
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Studying Pai syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cardiocentro Ticino
- Principal Investigator
- Marco Valgimigli, Cardiology Chief Prof. Dr. MedCardiocentro Ticino
- Intervention
- Clopidogrel(drug)
- Enrollment
- 355 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2028
Study locations (1)
- Istituto Cardiocentro Ticino, Lugano, Ch/ti, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07582835 on ClinicalTrials.gov